Auditors and other key financial advisers have been told to stop treating
clinical research group Huntingdon Life Sciences (HLS) as ‘radioactive’ and have
the courage to work with the group which has faced intense pressure from
Brian Cass, the head of the group, which uses animals in testing, pleaded
with auditors, banks, insurers and other advisers to shrug off fears of
intimidation and work with the company.
Animal activists targeting HLS have also targeted auditors and advisers in an
effort to shut the research firm down.
Speaking to the FT, Cass said: ‘There is still a perception in the
financial community that we are radioactive. We don’t have any special
difficulties and it’s mostly business as usual for us, but the message of
success still hasn’t [reached] the hierarchy.’
Cass was speaking as a group of individuals faced trial for allegedly
conspiring to blackmail suppliers to HLS.
Cass said it should be possible to use company legislation to conceal the
identity of auditors working with the company in order to protect them, in the
same way that director addresses could be kept confidential.
The second largest improvement in ‘significant’ levels of financial distress since the EU Referendum was in professional services, found research from Begbies Traynor
Does Darwin's theory apply to taxation? Colin ponders...
Two new audit partners have been appointed at the firm BDO in its audit practice following continued growth and investment
Investment in people, tech and businesses impacts on EY's profit per partner figure